These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 35585716)
1. Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR-103b/877-5p/29c-5p as diagnostic biomarkers for early lung adenocarcinoma. Wu J; Feng Z; Wang R; Li A; Wang H; He X; Shen Z Cancer Med; 2022 Dec; 11(23):4411-4421. PubMed ID: 35585716 [TBL] [Abstract][Full Text] [Related]
2. Identification of hsa-miR-619-5p and hsa-miR-4454 in plasma-derived exosomes as a potential biomarker for lung adenocarcinoma. Feng L; Feng Z; Hu J; Gao J; Li A; He X; Liu L; Shen Z Front Genet; 2023; 14():1138230. PubMed ID: 37252659 [No Abstract] [Full Text] [Related]
3. Tumor-derived circulating exosomal miR-342-5p and miR-574-5p as promising diagnostic biomarkers for early-stage Lung Adenocarcinoma. Han Z; Li Y; Zhang J; Guo C; Li Q; Zhang X; Lan Y; Gu W; Xing Z; Liang L; Li M; Mi S Int J Med Sci; 2020; 17(10):1428-1438. PubMed ID: 32624699 [TBL] [Abstract][Full Text] [Related]
4. Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma. Xue X; Wang C; Xue Z; Wen J; Han J; Ma X; Zang X; Deng H; Guo R; Asuquo IP; Qin C; Wang H; Gao Q; Liu S; Wang J Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):281-293. PubMed ID: 32073597 [TBL] [Abstract][Full Text] [Related]
5. Hypoxic tumor-derived exosomal miR-31-5p promotes lung adenocarcinoma metastasis by negatively regulating SATB2-reversed EMT and activating MEK/ERK signaling. Yu F; Liang M; Huang Y; Wu W; Zheng B; Chen C J Exp Clin Cancer Res; 2021 Jun; 40(1):179. PubMed ID: 34074322 [TBL] [Abstract][Full Text] [Related]
6. Identification of an Exosome-relevant SNHG6-hsa-miR-429- CHRDL1/CCNA2 Axis for Lung Adenocarcinoma Prognosis Evaluation. Yuan Y; Li Q; Chen F; Zhao Y; Ma J; Fang S Curr Med Chem; 2024; 31(28):4549-4561. PubMed ID: 38994652 [TBL] [Abstract][Full Text] [Related]
7. Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression. Chen HL; Luo YP; Lin MW; Peng XX; Liu ML; Wang YC; Li SJ; Yang DH; Yang ZX Cancer Med; 2022 Jul; 11(13):2627-2643. PubMed ID: 35347894 [TBL] [Abstract][Full Text] [Related]
8. A combination of four serum miRNAs for screening of lung adenocarcinoma. Wang J; Zhang C; Peng X; Liu K; Zhao L; Chen X; Yu H; Lai Y Hum Cell; 2020 Jul; 33(3):830-838. PubMed ID: 32388809 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing. Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918 [No Abstract] [Full Text] [Related]
10. Identification of exosomal hsa-miR-483-5p as a potential biomarker for hepatocellular carcinoma via microRNA expression profiling of tumor-derived exosomes. Lin J; Lin W; Bai Y; Liao Y; Lin Q; Chen L; Wu Y Exp Cell Res; 2022 Aug; 417(2):113232. PubMed ID: 35659970 [TBL] [Abstract][Full Text] [Related]
11. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728 [TBL] [Abstract][Full Text] [Related]
12. Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma. Ren ZP; Hou XB; Tian XD; Guo JT; Zhang LB; Xue ZQ; Deng JQ; Zhang SW; Pan JY; Chu XY FEBS Open Bio; 2019 Feb; 9(2):315-327. PubMed ID: 30761256 [TBL] [Abstract][Full Text] [Related]
13. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D. Sui MH; Zhang WW; Geng DM; Sun DJ Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800 [TBL] [Abstract][Full Text] [Related]
14. Exosomal microRNA-26b-5p down-regulates ATF2 to enhance radiosensitivity of lung adenocarcinoma cells. Han F; Huang D; Huang X; Wang W; Yang S; Chen S J Cell Mol Med; 2020 Jul; 24(14):7730-7742. PubMed ID: 32476275 [TBL] [Abstract][Full Text] [Related]
15. Serum exosomal miR-7977 as a novel biomarker for lung adenocarcinoma. Chen L; Cao P; Huang C; Wu Q; Chen S; Chen F J Cell Biochem; 2020 Jun; 121(5-6):3382-3391. PubMed ID: 31898829 [TBL] [Abstract][Full Text] [Related]
16. Application of miRNA Biomarkers in Predicting Overall Survival Outcomes for Lung Adenocarcinoma. Li T; Liu H; Dong C; Lyu J Biomed Res Int; 2022; 2022():5249576. PubMed ID: 36147635 [TBL] [Abstract][Full Text] [Related]
17. Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma. Gao S; Guo W; Liu T; Liang N; Ma Q; Gao Y; Tan F; Xue Q; He J Cancer Sci; 2022 Feb; 113(2):648-659. PubMed ID: 34837453 [TBL] [Abstract][Full Text] [Related]
18. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma. Tan J; Wang W; Song B; Song Y; Meng Z Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839 [TBL] [Abstract][Full Text] [Related]
19. Identification of Three Differentially Expressed miRNAs as Potential Biomarkers for Lung Adenocarcinoma Prognosis. Wang W; Liu B; Duan X; Feng X; Wang T; Wang P; Ding M; Zhang Q; Feng F; Wu Y; Yao W; Wang Q; Yang Y Comb Chem High Throughput Screen; 2020; 23(2):148-156. PubMed ID: 31976830 [TBL] [Abstract][Full Text] [Related]
20. A panel of miRNAs derived from plasma extracellular vesicles as novel diagnostic biomarkers of lung adenocarcinoma. Yao B; Qu S; Hu R; Gao W; Jin S; Liu M; Zhao Q FEBS Open Bio; 2019 Dec; 9(12):2149-2158. PubMed ID: 31677346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]